MITHRA PHARMACEUTICALS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2160 EUR | -1.82% |
|
-.--% | -82.78% |
| Jun. 11 | Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. acquired Neuralis and Estetra from Mithra Pharmaceuticals SA. | CI |
| May. 28 | Mithra Delays AGM Amid Monetization Process | MT |
Sales 2022 by Business Segment
Sales 2022 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Contract Research Organization | ||||||||||
Out-Licensing | - | - | 5.45M | 4.64M | 49.04M | |||||
Pharmaceutical Products | ||||||||||
Product Sales | - | - | 3.58M | 17.21M | 15.7M | |||||
Pharmaceuticals | 57.88M | 96.52M | - | - | - | |||||
Interest Expense | -5.36M | -3.32M | - | - | - | |||||
Income Tax Expense | -9.88M | -5.13M | - | - | - | |||||
Total Assets | 356M | 398M | - | - | - | |||||
CAPEX | -10.1M | -15.46M | - | - | - | |||||
EBT | -37.49M | -32.35M | - | - | - | |||||
Gross Profit | 56.31M | 94.03M | - | - | - | |||||
D&A | 2.85M | 5.43M | - | - | - | |||||
Operating Income | 14.19M | 26.05M | - | - | - | |||||
Net Income | -12.36M | -26.56M | - | - | - | |||||
Pharmaceutical Research and Development | ||||||||||
Others | - | - | - | 819K | 2.26M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe (Excl. Belgium) | - | - | - | 9.29M | 51.33M | |||||
outside Europe | 14.57M | 76.87M | 5.52M | 12.37M | 14.13M | |||||
Belgium | - | - | - | 1.01M | 1.54M | |||||
Total Assets | 194M | 306M | 284M | - | - | |||||
Europe | 43.3M | 19.65M | 3.51M | - | - | |||||
Other Countries | - | - | - | - | - | |||||
Total Assets | 6K | - | - | - | - | |||||
Total Assets | 8K | 7K | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Luxembourg | - | - | - | - | - | |||||
Total Assets | 6K | 6K | - | - | - | |||||
The Netherlands | - | - | - | - | - | |||||
Total Assets | 8M | - | - | - | - |
- Stock Market
- Equities
- MITRA Stock
- Financials Mithra Pharmaceuticals S.A.
- Business Segments